| First Author | Castillo AB | Year | 2014 |
| Journal | Am J Physiol Endocrinol Metab | Volume | 306 |
| Issue | 8 | Pages | E937-44 |
| PubMed ID | 24619882 | Mgi Jnum | J:212495 |
| Mgi Id | MGI:5581573 | Doi | 10.1152/ajpendo.00458.2013 |
| Citation | Castillo AB, et al. (2014) Estrogen receptor-beta regulates mechanical signaling in primary osteoblasts. Am J Physiol Endocrinol Metab 306(8):E937-44 |
| abstractText | Mechanical loading is an important regulator in skeletal growth, maintenance, and aging. Estrogen receptors have a regulatory role in mechanically induced bone adaptation. Estrogen receptor-alpha (ERalpha) is known to enhance load-induced bone formation, whereas ERbeta negatively regulates this process. We hypothesized that ERbeta regulates mechanical signaling in osteoblasts. We tested this hypothesis by subjecting primary calvarial cells isolated from wild-type and ERbeta-knockout mice (BERKO) to oscillatory fluid flow in the absence or presence of estradiol (E2). We found that the known responses to fluid shear stress, i.e., phosphorylation of the mitogen-activated protein kinase ERK and upregulation of COX-2 expression, were inhibited in BERKO cells in the absence of E2. Flow-induced increase in prostaglandin E2 (PGE2) release was not altered in BERKO cells in the absence of E2, but was increased when E2 was present. Additionally, immunofluorescence analysis and estrogen response element luciferase assays revealed increased ERalpha expression and flow- and ligand-induced nuclear translocation as well as transcriptional activity in BERKO cells in both the presence and absence of E2. Taken together, these data suggest that ERbeta plays both ligand-dependent and ligand-independent roles in mechanical signaling in osteoblasts. Furthermore, our data suggest that one mechanism by which ERbeta regulates mechanotransduction in osteoblasts may result from its inhibitory effect on ERalpha expression and function. Targeting estrogen receptors (e.g., inhibiting ERbeta) may represent an effective approach for prevention and treatment of age-related bone loss. |
